PSMA-specific CAR-T Cell Therapy

Clinical trial NCT04429451 · RECRUITING

Trial details

NCT number: NCT04429451
Sponsor: Shenzhen Geno-Immune Medical Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

PSMA Positive Tumors or Tumor Tissues

Start date: 2026-06-01
Primary completion: 2029-10-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.